INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Acadia Pharmaceuticals, Inc. (ACAD) To Contact The Firm

News provided by

Mar 13, 2015, 04:00 ET

NEW YORK, March 13, 2015 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential securities fraud at Acadia Pharmaceuticals, Inc. ("Acadia" or the "Company") (NASDAQ: ACAD).

The investigation focuses on whether the Company and its executives violated federal securities laws by issuance of certain statements.

On March 11, 2015, Acadia disclosed that it will delay submission of its New Drug Application for its experimental Parkinson's disease drug, nuplazid, from this quarter to sometime in the second half of the year. As well, Acadia announced that its long-time Chief Executive Officer will be stepping down.

Following this news, Acadia shares declined by $9.94 per share, or more than 22%, to close on March 12, 2015 at $34.82 per share.

Request more information now by clicking here: www.faruqilaw.com/ACAD. There is no cost or obligation to you.

Take Action

If you invested in Acadia stock or options through March 11, 2015 and would like to discuss your legal rights, visit www.faruqilaw.com/ACAD. You can also contact us by calling Richard Gonnello toll free at 877-247-4292 or at 212-983-9330 or by sending an e-mail to [email protected]. Faruqi & Faruqi, LLP also encourages anyone with information regarding Acadia's conduct to contact the firm, including whistleblowers, former employees, shareholders and others.

Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.

FARUQI & FARUQI, LLP
369 Lexington Avenue, 10th Floor
New York, NY 10017
Attn: Richard Gonnello, Esq.
[email protected]
Telephone: (877) 247-4292 or (212) 983-9330

Logo - http://photos.prnewswire.com/prnh/20120119/MM38856LOGO

SOURCE Faruqi & Faruqi, LLP